City

Chicago (2)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

University of Chicago (2)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

cetuximab (1)

pi3k inhibitor bkm120 (1)

quality-of-life assessment (1)

questionnaire administration (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

tongue cancer

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
+35 more

PI3K inhibitor BKM120
cetuximab

Chicago, Illinois

University of Chicago Comprehensive Cancer Center

Sep 14, 2021

Decisions in Patients With Stage I-IVA Oropharyngeal Cancer

Terminated

Stage I Squamous Cell Carcinoma of the Oropharynx
+4 more

questionnaire administration
quality-of-life assessment

Chicago, Illinois

University of Chicago Comprehensive Cancer Center

Sep 1, 2015